168 related articles for article (PubMed ID: 33840725)
1. Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg).
Nyssen OP; Perez-Aisa A; Tepes B; Castro-Fernandez M; Kupcinskas J; Jonaitis L; Bujanda L; Lucendo A; Jurecic NB; Perez-Lasala J; Shvets O; Fadeenko G; Huguet JM; Kikec Z; Bordin D; Voynovan I; Leja M; Machado JC; Areia M; Fernandez-Salazar L; Rodrigo L; Alekseenko S; Barrio J; Ortuño J; Perona M; Vologzhanina L; Romero PM; Zaytsev O; Rokkas T; Georgopoulos S; Pellicano R; Buzas GM; Modolell I; Gomez Rodriguez BJ; Simsek I; Simsek C; Lafuente MR; Ilchishina T; Camarero JG; Dominguez-Cajal M; Ntouli V; Dekhnich NN; Phull P; Nuñez O; Lerang F; Venerito M; Heluwaert F; Tonkic A; Caldas M; Puig I; Megraud F; O'Morain C; Gisbert JP;
Am J Gastroenterol; 2021 Jun; 116(6):1220-1229. PubMed ID: 33840725
[TBL] [Abstract][Full Text] [Related]
2. European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice.
Nyssen OP; Perez-Aisa A; Castro-Fernandez M; Pellicano R; Huguet JM; Rodrigo L; Ortuñ J; O ; Gomez-Rodriguez BJ; Pinto RM; Areia M; Perona M; Nuñez O; Romano M; Gravina AG; Pozzati L; Fernandez-Bermejo M; Venerito M; Malfertheiner P; Fernanadez-Salazar L; Gasbarrini A; Vaira D; Puig I; Megraud F; O'Morain C; Gisbert JP;
United European Gastroenterol J; 2021 Feb; 9(1):38-46. PubMed ID: 33176617
[TBL] [Abstract][Full Text] [Related]
3. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
Nyssen OP; Vaira D; Pérez Aísa Á; Rodrigo L; Castro-Fernandez M; Jonaitis L; Tepes B; Vologzhanina L; Caldas M; Lanas A; Lucendo AJ; Bujanda L; Ortuño J; Barrio J; Huguet JM; Voynovan I; Lasala JP; Sarsenbaeva AS; Fernandez-Salazar L; Molina-Infante J; Jurecic NB; Areia M; Gasbarrini A; Kupčinskas J; Bordin D; Marcos-Pinto R; Lerang F; Leja M; Buzas GM; Niv Y; Rokkas T; Phull P; Smith S; Shvets O; Venerito M; Milivojevic V; Simsek I; Lamy V; Bytzer P; Boyanova L; Kunovský L; Beglinger C; Doulberis M; Marlicz W; Goldis A; Tonkić A; Capelle L; Puig I; Megraud F; Morain CO; Gisbert JP;
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2243-2257. PubMed ID: 34954341
[TBL] [Abstract][Full Text] [Related]
4. European Registry on
Nyssen OP; Bordin D; Tepes B; Pérez-Aisa Á; Vaira D; Caldas M; Bujanda L; Castro-Fernandez M; Lerang F; Leja M; Rodrigo L; Rokkas T; Kupcinskas L; Pérez-Lasala J; Jonaitis L; Shvets O; Gasbarrini A; Simsek H; Axon ATR; Buzás G; Machado JC; Niv Y; Boyanova L; Goldis A; Lamy V; Tonkic A; Przytulski K; Beglinger C; Venerito M; Bytzer P; Capelle L; Milosavljević T; Milivojevic V; Veijola L; Molina-Infante J; Vologzhanina L; Fadeenko G; Ariño I; Fiorini G; Garre A; Garrido J; F Pérez C; Puig I; Heluwaert F; Megraud F; O'Morain C; Gisbert JP;
Gut; 2021 Jan; 70(1):40-54. PubMed ID: 32958544
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Nyssen OP; Pérez-Aisa Á; Tepes B; Rodrigo-Sáez L; Romero PM; Lucendo A; Castro-Fernández M; Phull P; Barrio J; Bujanda L; Ortuño J; Areia M; Brglez Jurecic N; Huguet JM; Alcaide N; Voynovan I; María Botargues Bote J; Modolell I; Pérez Lasala J; Ariño I; Jonaitis L; Dominguez-Cajal M; Buzas G; Lerang F; Perona M; Bordin D; Axon T; Gasbarrini A; Marcos Pinto R; Niv Y; Kupcinskas L; Tonkic A; Leja M; Rokkas T; Boyanova L; Shvets O; Venerito M; Bytzer P; Goldis A; Simsek I; Lamy V; Przytulski K; Kunovský L; Capelle L; Milosavljevic T; Caldas M; Garre A; Mégraud F; O'Morain C; Gisbert JP;
Helicobacter; 2020 Jun; 25(3):e12686. PubMed ID: 32173974
[TBL] [Abstract][Full Text] [Related]
6. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
[TBL] [Abstract][Full Text] [Related]
7. [Ten-day Sequential Therapy versus Bismuth Based Quadruple Therapy as Second Line Treatment for Helicobacter pylori Infection].
Kim SB; Lee SH; Kim KO; Jang BI; Kim TN
Korean J Gastroenterol; 2015 Nov; 66(5):261-7. PubMed ID: 26586348
[TBL] [Abstract][Full Text] [Related]
8. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
Nyssen OP; Perez-Aisa A; Rodrigo L; Castro M; Mata Romero P; Ortuño J; Barrio J; Huguet JM; Modollel I; Alcaide N; Lucendo A; Calvet X; Perona M; Gomez B; Gomez Rodriguez BJ; Varela P; Jimenez-Moreno M; Dominguez-Cajal M; Pozzati L; Burgos D; Bujanda L; Hinojosa J; Molina-Infante J; Di Maira T; Ferrer L; Fernández-Salazar L; Figuerola A; Tito L; de la Coba C; Gomez-Camarero J; Fernandez N; Caldas M; Garre A; Resina E; Puig I; O'Morain C; Megraud F; Gisbert JP
Helicobacter; 2020 Oct; 25(5):e12722. PubMed ID: 32656898
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of empirical
Bordin DS; Voynovan IN; Sarsenbaeva AS; Zaytsev OV; Abdulkhakov RA; Bakulina NV; Bakulin IG; Osipenko MF; Livzan MA; Alekseenko SA; Tarasova LV; Tarasova GN; Bogomolov PO; Maev IV; Andreev DN; Abdulkhakov SR; Starostin BD; Bakanova NV; Kononova AG; Kolbasnikov SV; Bueverova EL; Moreira L; Megraud F; O'Morain C; Perez Nyssen O; Gisbert J
Ter Arkh; 2023 Mar; 95(2):120-129. PubMed ID: 37167127
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management.
Gatta L; Nyssen OP; Fiorini G; Saracino IM; Pavoni M; Romano M; Gravina AG; Granata L; Pellicano R; Gasbarrini A; Di Leo A; Losurdo G; Franceschi F; Nardone G; Rocco A; Dore MP; Farinati F; Ghisa M; Bellini M; Holton J; Puig I; Vaira D; Borghi C; Mégraud F; O'Morain C; Gisbert JP
United European Gastroenterol J; 2023 Feb; 11(1):103-113. PubMed ID: 36565017
[TBL] [Abstract][Full Text] [Related]
11. Single-capsule bismuth-based quadruple therapy as a rescue therapy for
Correia C; Almeida N; Leal C; Branquinho D; Fernandes A; Gravito-Soares E; Calhau C; Bastos I; Vasconcelos H; Figueiredo P
Scand J Gastroenterol; 2023 Mar; 58(3):227-231. PubMed ID: 36189844
[TBL] [Abstract][Full Text] [Related]
12. Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Milivojevic V; Babic I; Kekic D; Rankovic I; Sagdati S; Panic N; Spasic IS; Krstic M; Milosavljevic T; Moreira L; Nyssen OP; Mégraud F; O' Morain C; Gisbert J
Dig Dis; 2023; 41(3):377-386. PubMed ID: 37253341
[TBL] [Abstract][Full Text] [Related]
13. [European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow].
Bordin DS; Voynovan IN; Embutnieks YV; Nyssen OP; Megraud F; O Morain C; Perez-Gisbert J
Ter Arkh; 2020 Apr; 92(2):12-18. PubMed ID: 32598712
[TBL] [Abstract][Full Text] [Related]
14. New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
Tursi A; Di Mario F; Franceschi M; De Bastiani R; Elisei W; Baldassarre G; Ferronato A; Grillo S; Landi S; Zamparella M; De Polo M; Boscariolo L; Picchio M
Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28125857
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
He XJ; Wang XL; Huang XY; Li DZ; Liu G; Wang W; Li DL
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102052. PubMed ID: 36400418
[TBL] [Abstract][Full Text] [Related]
16. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.
McNicholl AG; Bordin DS; Lucendo A; Fadeenko G; Fernandez MC; Voynovan I; Zakharova NV; Sarsenbaeva AS; Bujanda L; Perez-Aisa Á; Vologzhanina L; Zaytsev O; Ilchishina T; Coba C; Lasala JP; Alekseenko S; Modolell I; Molina-Infante J; Ruiz-Zorrilla Lopez R; Alonso-Galan H; Moreno NF; Hinojosa J; Santaella I; Varela P; Gonzalez-Cordero PL; Barrio J; Dominguez-Jimenez JL; Nuñez O; Alcedo J; Nyssen OP; Caldas M; Donday MG; Shvetz O; Megraud F; O'Morain C; Gisbert JP
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):89-98. PubMed ID: 30978536
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.
Miehlke S; Frederking D; Günther T; Glocker E; Eisele B; Andresen V; Schröder S; Morgner A
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28833925
[TBL] [Abstract][Full Text] [Related]
18. [The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].
Kwon S; Lee DH; Kang JB; Kim N; Park YS; Shin CM; Yoon H; Choi YJ
Korean J Gastroenterol; 2018 Apr; 71(4):196-203. PubMed ID: 29684968
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
[TBL] [Abstract][Full Text] [Related]
20. [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan].
Abdulkhakov SR; Bordin DS; Abdulkhakov RA; Safina DD; Gizdatullina AR; Gimadieva LZ; Safina GM; Ziyatdinov AI; Maturina AM; Nyssen OP; Megraud F; O'Morain C; Perez-Gisbert J
Ter Arkh; 2020 Sep; 92(8):52-59. PubMed ID: 33346462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
